Skip to main content
Erschienen in: Drug Safety 1/2008

01.01.2008 | Review Article

Methods for Causality Assessment of Adverse Drug Reactions

A Systematic Review

verfasst von: Taofikat B. Agbabiaka, Jelena Savović, Edzard Ernst

Erschienen in: Drug Safety | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Numerous methods for causality assessment of adverse drug reactions (ADRs) have been published. The aim of this review is to provide an overview of these methods and discuss their strengths and weaknesses. We conducted electronic searches in MEDLINE (via PubMed), EMBASE and the Cochrane databases to find all assessment methods. Thirty-four different methods were found, falling into three broad categories: expert judgement/global introspection, algorithms and probabilistic methods (Bayesian approaches). Expert judgements are individual assessments based on previous knowledge and experience in the field using no standardized tool to arrive at conclusions regarding causality. Algorithms are sets of specific questions with associated scores for calculating the likelihood of a cause-effect relationship. Bayesian approaches use specific findings in a case to transform the prior estimate of probability into a posterior estimate of probability of drug causation. The prior probability is calculated from epidemiological information and the posterior probability combines this background information with the evidence in the individual case to come up with an estimate of causation. As a result of problems of reproducibility and validity, no single method is universally accepted. Different causality categories are adopted in each method, and the categories are assessed using different criteria. Because assessment methods are also not entirely devoid of individual judgements, inter-rater reliability can be low. In conclusion, there is still no method universally accepted for causality assessment of ADRs.
Literatur
1.
Zurück zum Zitat Schneeweiss S, Hasford J, Gottler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285–91PubMedCrossRef Schneeweiss S, Hasford J, Gottler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285–91PubMedCrossRef
2.
Zurück zum Zitat Prince BS, Goetz CM, Rihn TL, et al. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 1992; 49: 1696–700PubMed Prince BS, Goetz CM, Rihn TL, et al. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 1992; 49: 1696–700PubMed
3.
Zurück zum Zitat Liu BA, Knowles SR, Mittmann N, et al. Reporting of fatal adverse drug reactions. Can J Clin Pharmacol 2001; 8: 84–8PubMed Liu BA, Knowles SR, Mittmann N, et al. Reporting of fatal adverse drug reactions. Can J Clin Pharmacol 2001; 8: 84–8PubMed
4.
Zurück zum Zitat Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef
6.
Zurück zum Zitat Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf 2005; 14: 885–90PubMedCrossRef Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf 2005; 14: 885–90PubMedCrossRef
7.
Zurück zum Zitat Arimone Y, Begaud B, Miremont-Salame G, et al. Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 2005; 61: 169–73PubMedCrossRef Arimone Y, Begaud B, Miremont-Salame G, et al. Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 2005; 61: 169–73PubMedCrossRef
8.
Zurück zum Zitat Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 85: 295–300 Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 85: 295–300
9.
Zurück zum Zitat Hutchinson TA, Lane DA. Assessing methods for causality assessment of suspected adverse drug reactions. J Clin Epidemiol 1989; 42: 5–16PubMedCrossRef Hutchinson TA, Lane DA. Assessing methods for causality assessment of suspected adverse drug reactions. J Clin Epidemiol 1989; 42: 5–16PubMedCrossRef
10.
Zurück zum Zitat Wiholm BE. The Swedish drug-event assessment methods. Special workshop — regulatory. Drug Inf J 1984; 18: 267–9PubMed Wiholm BE. The Swedish drug-event assessment methods. Special workshop — regulatory. Drug Inf J 1984; 18: 267–9PubMed
11.
Zurück zum Zitat Miremont G, Haramburu F, Begaud B, et al. Adverse drug reactions: physicians’ opinions versus a causality assessment method. Eur J Clin Pharmacol 1994; 46: 285–9PubMedCrossRef Miremont G, Haramburu F, Begaud B, et al. Adverse drug reactions: physicians’ opinions versus a causality assessment method. Eur J Clin Pharmacol 1994; 46: 285–9PubMedCrossRef
12.
Zurück zum Zitat Irey NS. Tissue reactions to drugs. Am J Pathol 1976; 82: 613–48PubMed Irey NS. Tissue reactions to drugs. Am J Pathol 1976; 82: 613–48PubMed
13.
Zurück zum Zitat Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–54PubMed Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–54PubMed
14.
Zurück zum Zitat Dangoumau J, Evreux JC, Jouglard J. Method for determination of undesirable effects of drugs [in French]. Therapie 1978; 33: 373–81PubMed Dangoumau J, Evreux JC, Jouglard J. Method for determination of undesirable effects of drugs [in French]. Therapie 1978; 33: 373–81PubMed
15.
Zurück zum Zitat Begaud B, Evreux JC, Jouglard J, et al. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France. Therapie 1985; 40: 111–8PubMed Begaud B, Evreux JC, Jouglard J, et al. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France. Therapie 1985; 40: 111–8PubMed
16.
Zurück zum Zitat Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. JAMA 1979; 242: 623–32 36PubMedCrossRef Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. JAMA 1979; 242: 623–32 36PubMedCrossRef
17.
Zurück zum Zitat Blanc S, Leuenberger P, Berger JP, et al. Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979; 25: 493–8PubMed Blanc S, Leuenberger P, Berger JP, et al. Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979; 25: 493–8PubMed
18.
Zurück zum Zitat Emanueli A, Sacchetti G. An algorithm for the classification of untoward events in large scale clinical trials. Agents Actions Suppl. 1980; 7: 318–22PubMed Emanueli A, Sacchetti G. An algorithm for the classification of untoward events in large scale clinical trials. Agents Actions Suppl. 1980; 7: 318–22PubMed
19.
Zurück zum Zitat Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef
20.
Zurück zum Zitat Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting. Fam Community Health 1982; 5: 58–67PubMedCrossRef Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting. Fam Community Health 1982; 5: 58–67PubMedCrossRef
21.
Zurück zum Zitat Evreux JC, Loupi E, Descotes J, et al. Evaluation of the documentation on adverse effects of drugs: proposition 2. Imputability [in French]. Therapie 1982; 37: 657–70PubMed Evreux JC, Loupi E, Descotes J, et al. Evaluation of the documentation on adverse effects of drugs: proposition 2. Imputability [in French]. Therapie 1982; 37: 657–70PubMed
22.
Zurück zum Zitat Kitaguchi T, Nojiri T, Suzuki S, et al. Some assessment systems for industry post marketing adverse drug reaction (ADR) Information. Iyakuhin Kenkyu 1983; 14: 980–92 Kitaguchi T, Nojiri T, Suzuki S, et al. Some assessment systems for industry post marketing adverse drug reaction (ADR) Information. Iyakuhin Kenkyu 1983; 14: 980–92
23.
Zurück zum Zitat Lagier G, Vincens M, Castot A. Imputability in drug monitoring: principles of the balanced drug reaction assessment method and principal errors to avoid. Therapie 1983; 38: 303–18PubMed Lagier G, Vincens M, Castot A. Imputability in drug monitoring: principles of the balanced drug reaction assessment method and principal errors to avoid. Therapie 1983; 38: 303–18PubMed
24.
Zurück zum Zitat Cornelli U. The phase IV monitoring studies: example of Naproxen Na multi-centre Italian trial. In: Crescioni C, James JM, editors. ostmarketing clinical trials — the phase V studies. Paris: Editions de Sante, 1984: 89–105 Cornelli U. The phase IV monitoring studies: example of Naproxen Na multi-centre Italian trial. In: Crescioni C, James JM, editors. ostmarketing clinical trials — the phase V studies. Paris: Editions de Sante, 1984: 89–105
25.
Zurück zum Zitat Stephens MD. Assessment of causality in industrial setting. Special workshop — industrial. Drug Inf J 1984; 18: 307–13 Stephens MD. Assessment of causality in industrial setting. Special workshop — industrial. Drug Inf J 1984; 18: 307–13
26.
Zurück zum Zitat Castle WM. Assessment of causality in industrial settings. Drug Inf J 1984; 18: 297–302 Castle WM. Assessment of causality in industrial settings. Drug Inf J 1984; 18: 297–302
27.
Zurück zum Zitat Turner WM. The Food and Drug Administration algorithm. Special workshop — regulatory. Drug Inf J 1984; 18: 259–66PubMed Turner WM. The Food and Drug Administration algorithm. Special workshop — regulatory. Drug Inf J 1984; 18: 259–66PubMed
28.
Zurück zum Zitat Venulet J, Ciucci A, Berneker GC. Standardised assessment of drug-adverse reaction associations: rationale and experience. Int J Clin Pharmacol Ther Toxicol 1980; 18: 381–8PubMed Venulet J, Ciucci A, Berneker GC. Standardised assessment of drug-adverse reaction associations: rationale and experience. Int J Clin Pharmacol Ther Toxicol 1980; 18: 381–8PubMed
29.
Zurück zum Zitat Loupi E, Ponchon AC, Ventre JJ, et al. Imputability of a teratogenic effect [in French]. Therapie 1986; 41: 207–10PubMed Loupi E, Ponchon AC, Ventre JJ, et al. Imputability of a teratogenic effect [in French]. Therapie 1986; 41: 207–10PubMed
30.
Zurück zum Zitat Stricker BHC. Diagnosis and causality assessment of drug-induced hepatic injury. In: Dukes MNG, ed. Drug-induced hepatic injury. Amsterdam: Elsevier, 1985: 1–13 Stricker BHC. Diagnosis and causality assessment of drug-induced hepatic injury. In: Dukes MNG, ed. Drug-induced hepatic injury. Amsterdam: Elsevier, 1985: 1–13
31.
Zurück zum Zitat Benichou C, Danan G. Causality assessment in the European pharmaceutical industry: presentation of the preliminary results of a new method. Drug Inf J 1992; 26: 589–92CrossRef Benichou C, Danan G. Causality assessment in the European pharmaceutical industry: presentation of the preliminary results of a new method. Drug Inf J 1992; 26: 589–92CrossRef
32.
Zurück zum Zitat Hoskins RE, Mannino S. Causality assessment of adverse drug reactions using decision support and informatics tools. Pharmacoepidemiol Drug Saf 1992; 1: 235–49CrossRef Hoskins RE, Mannino S. Causality assessment of adverse drug reactions using decision support and informatics tools. Pharmacoepidemiol Drug Saf 1992; 1: 235–49CrossRef
33.
Zurück zum Zitat Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323–30PubMedCrossRef Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323–30PubMedCrossRef
34.
Zurück zum Zitat Hsu PH, Stoll RW. Causality assessment of adverse events in clinical trials: II. An algorithm for drug causality assessment. Drug Inf J 1993; 27: 387–94CrossRef Hsu PH, Stoll RW. Causality assessment of adverse events in clinical trials: II. An algorithm for drug causality assessment. Drug Inf J 1993; 27: 387–94CrossRef
35.
Zurück zum Zitat Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664–9PubMedCrossRef Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664–9PubMedCrossRef
36.
Zurück zum Zitat Koh Y, Shu CL. A new algorithm to identify the causality of adverse drug reactions. Drug Saf 2005; 28: 1159–61PubMedCrossRef Koh Y, Shu CL. A new algorithm to identify the causality of adverse drug reactions. Drug Saf 2005; 28: 1159–61PubMedCrossRef
37.
Zurück zum Zitat Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007; 41: 674–80PubMedCrossRef Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007; 41: 674–80PubMedCrossRef
38.
Zurück zum Zitat Mashford ML. The Australian method of drug-event assessment. Special Workshop — regulatory. Drug Inf J 1984; 18: 271–3PubMed Mashford ML. The Australian method of drug-event assessment. Special Workshop — regulatory. Drug Inf J 1984; 18: 271–3PubMed
39.
Zurück zum Zitat Lane DA, Kramer MS, Hutchinson TA, et al. The causality assessment of adverse drug reactions using a Bayesian approach. Pharm Med 1987; 2: 265–83 Lane DA, Kramer MS, Hutchinson TA, et al. The causality assessment of adverse drug reactions using a Bayesian approach. Pharm Med 1987; 2: 265–83
40.
Zurück zum Zitat Hutchinson TA, Dawid AP, Spiegelhalter DJ, et al. Computerized aids for probabilistic assessment of drug safety: I. A spreadsheet program. Drug Inf J 1991; 25: 29–39CrossRef Hutchinson TA, Dawid AP, Spiegelhalter DJ, et al. Computerized aids for probabilistic assessment of drug safety: I. A spreadsheet program. Drug Inf J 1991; 25: 29–39CrossRef
41.
Zurück zum Zitat Hutchinson TA. Computerized Bayesian ADE assessment. Drug Inf J 1991; 25: 235–41CrossRef Hutchinson TA. Computerized Bayesian ADE assessment. Drug Inf J 1991; 25: 235–41CrossRef
42.
Zurück zum Zitat Lanctot KL, Kwok MCO, Naranjo CA. Computerized Bayesian evaluation of adverse events. Drug Inf J 1995; 29: 319–25CrossRef Lanctot KL, Kwok MCO, Naranjo CA. Computerized Bayesian evaluation of adverse events. Drug Inf J 1995; 29: 319–25CrossRef
43.
Zurück zum Zitat Meyboom RHB, Hekster YA, Egberts ACG, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374–89PubMedCrossRef Meyboom RHB, Hekster YA, Egberts ACG, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374–89PubMedCrossRef
44.
Zurück zum Zitat Meyboom RHB. Causality assessment revisited. Pharmacoepidemiol Drug Saf 1998; 7 Suppl. 1:S63–5PubMedCrossRef Meyboom RHB. Causality assessment revisited. Pharmacoepidemiol Drug Saf 1998; 7 Suppl. 1:S63–5PubMedCrossRef
45.
Zurück zum Zitat Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 2003; 28: 137–43PubMedCrossRef Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 2003; 28: 137–43PubMedCrossRef
46.
Zurück zum Zitat Karch FE, Smith CL, Kerzner B, et al. Adverse drug reactions: a matter of opinion. Clin Pharmacol Ther 1976; 19: 489–92PubMed Karch FE, Smith CL, Kerzner B, et al. Adverse drug reactions: a matter of opinion. Clin Pharmacol Ther 1976; 19: 489–92PubMed
47.
Zurück zum Zitat Arimone Y, Begaud B, Miremont-Salame G, et al. A new method for assessing drug causation provided agreement with experts’ judgment. J Clin Epidemiol 2006; 59: 308–14PubMedCrossRef Arimone Y, Begaud B, Miremont-Salame G, et al. A new method for assessing drug causation provided agreement with experts’ judgment. J Clin Epidemiol 2006; 59: 308–14PubMedCrossRef
48.
Zurück zum Zitat Venulet J. Aspects of standardization as applied to the assessment of drug-event associations. Drug Inf J 1984; 18: 199–210PubMed Venulet J. Aspects of standardization as applied to the assessment of drug-event associations. Drug Inf J 1984; 18: 199–210PubMed
49.
Zurück zum Zitat Begaud B. Standardized assessment of adverse drug reactions: the method used in France. Special workshop — clinical. Drug Inf J 1984; 18: 275–81PubMed Begaud B. Standardized assessment of adverse drug reactions: the method used in France. Special workshop — clinical. Drug Inf J 1984; 18: 275–81PubMed
50.
Zurück zum Zitat Lanctot KL, Naranjo CA. Computer-assisted evaluation of adverse events using a Bayesian approach. J Clin Pharmacol 1994; 34: 142–7PubMed Lanctot KL, Naranjo CA. Computer-assisted evaluation of adverse events using a Bayesian approach. J Clin Pharmacol 1994; 34: 142–7PubMed
51.
Zurück zum Zitat Leventhal JM, Hutchinson TA, Kramer MS, et al. An algorithm for the operational assessment of adverse drug reactions: III. Results of tests among clinicians. JAMA 1979; 242: 1991–4PubMedCrossRef Leventhal JM, Hutchinson TA, Kramer MS, et al. An algorithm for the operational assessment of adverse drug reactions: III. Results of tests among clinicians. JAMA 1979; 242: 1991–4PubMedCrossRef
52.
Zurück zum Zitat Venulet J. Recognition and assessment of adverse drug reactions in children. Bratisl Lek Listy 1991; 92: 540–3PubMed Venulet J. Recognition and assessment of adverse drug reactions in children. Bratisl Lek Listy 1991; 92: 540–3PubMed
53.
Zurück zum Zitat Frick PA, Cohen LG, Rovers JP. Algorithms used in adverse drug event reports: a comparative study. Ann of Pharmacother 1997; 31: 164–7 Frick PA, Cohen LG, Rovers JP. Algorithms used in adverse drug event reports: a comparative study. Ann of Pharmacother 1997; 31: 164–7
54.
Zurück zum Zitat Hutchinson TA, Leventhal JM, Kramer MS, et al. An algorithm for the operational assessment of adverse drug reactions: II. Demonstration of reproducibility and validity. JAMA 1979; 242: 633–8PubMedCrossRef Hutchinson TA, Leventhal JM, Kramer MS, et al. An algorithm for the operational assessment of adverse drug reactions: II. Demonstration of reproducibility and validity. JAMA 1979; 242: 633–8PubMedCrossRef
55.
56.
Zurück zum Zitat Kane-Gill SL, Kirisci L, Pathak DS. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit? Ann Pharmacother 2005; 39: 1823–7PubMedCrossRef Kane-Gill SL, Kirisci L, Pathak DS. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit? Ann Pharmacother 2005; 39: 1823–7PubMedCrossRef
57.
Zurück zum Zitat Venulet J, Ciucci AG, Berneker GC. Updating of a method for causality assessment of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol 1986; 24: 559–68PubMed Venulet J, Ciucci AG, Berneker GC. Updating of a method for causality assessment of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol 1986; 24: 559–68PubMed
58.
Zurück zum Zitat Benichou C. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990; 11: 272–6PubMedCrossRef Benichou C. Criteria of drug-induced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990; 11: 272–6PubMedCrossRef
59.
Zurück zum Zitat Naranjo CA, Lane D, Ho-Asjoe M, et al. A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barre syndrome and zimeldine. J Clin Pharmacol 1990; 30: 174–80PubMed Naranjo CA, Lane D, Ho-Asjoe M, et al. A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barre syndrome and zimeldine. J Clin Pharmacol 1990; 30: 174–80PubMed
60.
Zurück zum Zitat Naranjo CA, Lanctot KL. A consultant’s view on the role of Bayesian differential diagnosis in the safety assessment of pharmaceuticals. Drug Inf J 1992; 26: 593–601CrossRef Naranjo CA, Lanctot KL. A consultant’s view on the role of Bayesian differential diagnosis in the safety assessment of pharmaceuticals. Drug Inf J 1992; 26: 593–601CrossRef
61.
Zurück zum Zitat Naranjo CA, Lanctot KL, Lane DA. The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agents. J Clin Pharmacol 1990; 30: 1120–7PubMed Naranjo CA, Lanctot KL, Lane DA. The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agents. J Clin Pharmacol 1990; 30: 1120–7PubMed
62.
Zurück zum Zitat Pere JC, Begaud B, Haramburu F, et al. Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmacol Ther 1986; 40: 451–61PubMedCrossRef Pere JC, Begaud B, Haramburu F, et al. Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmacol Ther 1986; 40: 451–61PubMedCrossRef
63.
Zurück zum Zitat Ennis M, Ohmann C, Lorenz W, et al. Prediction of risk for pseudoallergic reactions and histamine release in patients undergoing 37 anaesthesia and surgery: a computer-aided model using independence-Bayes. Agents Actions 1988; 23: 366–9PubMedCrossRef Ennis M, Ohmann C, Lorenz W, et al. Prediction of risk for pseudoallergic reactions and histamine release in patients undergoing 37 anaesthesia and surgery: a computer-aided model using independence-Bayes. Agents Actions 1988; 23: 366–9PubMedCrossRef
64.
Zurück zum Zitat Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977; 11: 75–8PubMedCrossRef Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977; 11: 75–8PubMedCrossRef
65.
Zurück zum Zitat Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs: II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331–6PubMedCrossRef Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs: II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331–6PubMedCrossRef
66.
Zurück zum Zitat Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 1986; 43: 1709–14PubMed Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 1986; 43: 1709–14PubMed
67.
Zurück zum Zitat Busto U, Naranjo CA, Sellers EM. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmacol 1982; 13: 223–7PubMedCrossRef Busto U, Naranjo CA, Sellers EM. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmacol 1982; 13: 223–7PubMedCrossRef
68.
Zurück zum Zitat Kramer MS. Assessing causality of adverse drug reactions: global introspection and its limitations. Drug Inf J 1986; 20: 433–7 Kramer MS. Assessing causality of adverse drug reactions: global introspection and its limitations. Drug Inf J 1986; 20: 433–7
69.
Zurück zum Zitat Hutchinson TA, Flegel KM, HoPingKong H, et al. Reasons for disagreement in the standardized assessment of suspected adverse drug reactions. Clin Pharmacol Ther 1983; 34: 421–6PubMedCrossRef Hutchinson TA, Flegel KM, HoPingKong H, et al. Reasons for disagreement in the standardized assessment of suspected adverse drug reactions. Clin Pharmacol Ther 1983; 34: 421–6PubMedCrossRef
70.
Zurück zum Zitat Stephens MD. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987; 6: 1–35PubMed Stephens MD. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987; 6: 1–35PubMed
71.
Zurück zum Zitat Naranjo CA, Kwok MC, Lanctot KL, et al. Enhanced differential diagnosis of anticonvulsant hypersensitivity reactions by an integrated Bayesian and biochemical approach. Clin Pharmacol Ther 1994; 56: 564–75PubMedCrossRef Naranjo CA, Kwok MC, Lanctot KL, et al. Enhanced differential diagnosis of anticonvulsant hypersensitivity reactions by an integrated Bayesian and biochemical approach. Clin Pharmacol Ther 1994; 56: 564–75PubMedCrossRef
72.
Zurück zum Zitat Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005; 28: 851–70PubMedCrossRef Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005; 28: 851–70PubMedCrossRef
73.
Zurück zum Zitat Castle W. Adverse drug reactions: scope and limitations of causality assessment and the use of algorithms. Int J Risk Saf Med 1991; 2: 185–91 Castle W. Adverse drug reactions: scope and limitations of causality assessment and the use of algorithms. Int J Risk Saf Med 1991; 2: 185–91
74.
Zurück zum Zitat Kelly WN. The quality of published adverse drug event reports: review. Ann Pharmacother 2003; 37: 1774–8PubMedCrossRef Kelly WN. The quality of published adverse drug event reports: review. Ann Pharmacother 2003; 37: 1774–8PubMedCrossRef
Metadaten
Titel
Methods for Causality Assessment of Adverse Drug Reactions
A Systematic Review
verfasst von
Taofikat B. Agbabiaka
Jelena Savović
Edzard Ernst
Publikationsdatum
01.01.2008
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 1/2008
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200831010-00003

Weitere Artikel der Ausgabe 1/2008

Drug Safety 1/2008 Zur Ausgabe